HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells
Martine Auclair(Inserm), Jacqueline Capeau(Inserm)
Cited by 39